Stay updated on Nivolumab Post Induction in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Post Induction in NSCLC Clinical Trial page.

Latest updates to the Nivolumab Post Induction in NSCLC Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe footer now shows Revision: v3.5.4, replacing the prior v3.5.3. This appears to be a small platform update and does not change the study details or navigation.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check29 days agoChange DetectedThe page revision indicator was updated from v3.5.2 to v3.5.3, reflecting a website release without altering the study content.SummaryDifference0.1%

- Check36 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check65 days agoChange DetectedThe page now displays Revision: v3.5.0, replacing Revision: v3.4.3.SummaryDifference0.1%

- Check72 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check100 days agoChange DetectedAdded Revision: v3.4.2 and removed the prior Revision: v3.4.1 along with the government funding/status notice.SummaryDifference0.5%

Stay in the know with updates to Nivolumab Post Induction in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Post Induction in NSCLC Clinical Trial page.